Baseline clinical characteristics, comorbidities and prescribed medication in a real-world population of patients with idiopathic pulmonary fibrosis: the PROOF registry.

Wuyts, Wim A; Dahlqvist, Caroline; Slabbynck, Hans; Schlesser, Marc; Gusbin, Natacha; Compere, Christophe; Maddens, Sofie; Kirchgaessler, Klaus-Uwe; Bartley, Karen; Bondue, Benjamin

Wuyts, Wim A; Dahlqvist, Caroline; Slabbynck, Hans; Schlesser, Marc; Gusbin, Natacha; Compere, Christophe; Maddens, Sofie; Kirchgaessler, Klaus-Uwe; Bartley, Karen; Bondue, Benjamin.

Afiliação

Wuyts WA; Department of Respiratory Medicine, University Hospitals Leuven, Leuven, Belgium.
Dahlqvist C; CHU UCL Dinant Godinne, Yvoir, Belgium.
Slabbynck H; Department of Respiratory Medicine, ZNA Middelheim, Antwerp, Belgium.
Schlesser M; Department of Respiratory Medicine, Centre Hospitalier de Luxembourg, Luxembourg City, Luxembourg.
Gusbin N; CHR de la Citadelle, Liège, Belgium.
Compere C; CHIREC Hospital, Brussels, Belgium.
Maddens S; AZ Groeninge, Kortrijk, Belgium.
Kirchgaessler KU; F. Hoffmann-La Roche, Ltd.,, Basel, Switzerland.
Bartley K; Genentech, Inc., South San Francisco, California, USA.
Bondue B; Department of Respiratory Medicine, Erasme University Hospital, Brussels, Belgium.

BMJ Open Respir Res ; 5(1): e000331, 2018.

Article em En | MEDLINE | ID: mdl-30555708

Palavras-chave

interstitial fibrosis; rare lung diseases

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: BMJ Open Respir Res Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Bélgica

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google